Chemiluminescence Immunoassay Market is estimated to be US$ 11.4 billion by 2032 with a CAGR of 8.1% over the forecast period (2022-2032)

Download Sample

Published Date: February 2023

Increasing awareness of early diagnosis of chronic diseases and increasing drug discovery and development activities of pharmaceutical companies are considered high-impact drivers for the Chemiluminescence Immunoassay market. Several researchers have found that using of novel and validated biomarkers can lead to early diagnosis of various cancers. The COVID-19 pandemic has also been crucial in shaping the clinical diagnostic industry, as there was urgent need to aid the development in diagnostics sector. Wherein, Chemiluminescence Immunoassay test were approved by FDA, to provide rapid results.

Further, the market is driven by several factors, such as increasing innovation development of CLIA systems by market players, integration of technological advancements to and increasing demand for such diagnostic techniques to address the growing global disease-ridden population.

The report “Chemiluminescence Immunoassay Market, By Product (Consumables, Instruments, Software & Services), By Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease), By End User (Hospitals and Clinics, Medical and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Research Institutes),and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends Analysis and Forecast till 2032 “

Key Highlights:

In July 2022, Roche announced the launch of the Elecsys HCV Duo immunoassay in countries accepting the CE mark. The Elecsys HCV Duo is the first available immunoassay that allows simultaneous and independent determination of hepatitis C virus (HIV) antigen and antibody status from a single human plasma or serum sample.
In December 2022, Mindray launched a CLIA inflammation solution: IL-6, PCT and Scd14-ST.
In May 2019, Food and Drug Administration (FDA) approved Inova Diagnostics new QUANTA Flash RF IgA and QUANTA Flash Rheumatoid Factor (RF) IgM chemiluminescent assays.

Analyst View:

Chemiluminescent analytical method remains in wide dynamic range, high signal intensity, absence of interference emissions (i.e. high specificity), and fast acquisition of analytical signal, high stability of reagents and, low consumption of reagents, which supports the growth of Chemiluminescence Immunoassay Market.

Further, increasing usage of immunoassays in areas of pharmaceutical analysis such as clinical pharmacokinetic and bioequivalence studies in the pharmaceutical industry, also supports the growth of Chemiluminescence Immunoassay Market.

Browse 60 market data tables and 35 figures* through 140 slides and in-depth TOC on* “Chemiluminescence Immunoassay Market, By Product (Consumables, Instruments, Software & Services), By Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease), By End User (Hospitals and Clinics, Medical and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Research Institutes), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Chemiluminescence-Immunoassay-Market-5033

Key Market Insights from the report:

Chemiluminescence Immunoassay Market accounted for US$ 6.3 billion in 2022 and is estimated to be US$ 11.4billion by 2032 and is anticipated to register a CAGR of 8.1%. The Chemiluminescence Immunoassay Market is segmented based on Product, Application, End User and Region.

Based on Product, Chemiluminescence Immunoassay Market is segmented into Consumables, Instruments, and Software & Services.
Based on Application, Chemiluminescence Immunoassay Market is segmented into Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, and Autoimmune Disease.
Based on End User, Chemiluminescence Immunoassay Market is segmented into Hospitals and Clinics, Medical and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Research Institutes.
By Region, the Chemiluminescence Immunoassay Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Chemiluminescence Immunoassay Market:

The prominent players operating in the Chemiluminescence Immunoassay Market includes, DiaSorin S.p.A., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers, Beckman Coulter Inc., F.Hoffmann-La Roche AG, Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd., Ortho Clinical Diagnostics, Tosoh Corporation. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period